SG Americas Securities
RUBY

SG Americas Securities’s Rubius Therapeutics, Inc RUBY Stock Holding History

SG Americas Securities’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,226
Closed -$4K – 3653
2022
Q4 		$4K Hold
22,226
– – ﹤0.01% 3001
2022
Q3 		$10K Buy
22,226
+79
+0.4% +$59 ﹤0.01% 3121
2022
Q2 		$19K Sell
22,147
-6,739
-23% -$11.3K ﹤0.01% 3343
2022
Q1 		$159K Sell
28,886
-1,210
-4% -$7.68K ﹤0.01% 2551
2021
Q4 		$291K Sell
30,096
-15,395
-34% -$213K ﹤0.01% 2456
2021
Q3 		$813K Buy
45,491
+19,885
+78% +$433K ﹤0.01% 2082
2021
Q2 		$625K Sell
25,606
-5,059
-16% -$127K ﹤0.01% 1843
2021
Q1 		$813K Sell
30,665
-1,700
-5% -$24.8K ﹤0.01% 1683
2020
Q4 		$246K Buy
32,365
+18,027
+126% +$107K ﹤0.01% 2508
2020
Q3 		$72K Sell
14,338
-28,101
-66% -$149K ﹤0.01% 2489
2020
Q2 		$254K Buy
42,439
+8,008
+23% +$47.3K ﹤0.01% 2654
2020
Q1 		$153K Buy
34,431
+17,422
+102% +$129K ﹤0.01% 2703
2019
Q4 		$162K Sell
17,009
-2,737
-14% -$26.5K ﹤0.01% 2636
2019
Q3 		$155K Buy
+19,746
New +$230K ﹤0.01% 2493
2019
Q2 		– Sell
-6,462
Closed -$117K – 3536
2019
Q1 		$117K Buy
+6,462
New +$99.2K ﹤0.01% 2959

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

SG Americas Securities's RUBY Position: Q1 2023 in Review

SG Americas Securities sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 22,226 shares — an estimated $4K sold.

SG Americas Securities first reported a position in RUBY in Q1 2019 and held it in 15 quarters. The position peaked at $813K in Q3 2021. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • SG Americas Securities reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • SG Americas Securities sold 22,226 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $4K.
  • SG Americas Securities first reported a position in Rubius Therapeutics, Inc in Q1 2019 and held it in 15 quarters.
  • SG Americas Securities's Rubius Therapeutics, Inc position peaked at $813K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on SG Americas Securities's 13F filing for Q1 2023, filed 28 Apr 2023.